PURPOSE: To study the feasibility of using 2-deoxy-D-glucose (2-DG)-labeled gold nanoparticle (AuNP-DG) as a computed tomography (CT) contrast agent with tumor targeting capability through in vitro experiments. PROCEDURES: Gold nanoparticles (AuNP) were fabricated and were conjugated with 2-deoxy-D-glucose. The human alveolar epithelial cancer cell line, A-549, was chosen for the in vitro cellular uptake assay. Two groups of cell samples were incubated with the AuNP-DG and the unlabeled AuNP, respectively. Following the incubation, the cells were washed with sterile PBS to remove the excess gold nanoparticles and spun to cell pellets using a centrifuge. The cell pellets were imaged using a microCT scanner immediately after the centrifugation. The reconstructed CT images were analyzed using a commercial software package. RESULTS: Significant contrast enhancement in the cell samples incubated with the AuNP-DG with respect to the cell samples incubated with the unlabeled AuNP was observed in multiple CT slices. CONCLUSIONS: Results from this study demonstrate enhanced uptake of 2-DG-labeled gold nanoparticle by cancer cells in vitro and warrant further experiments to study the exact molecular mechanism by which the AuNP-DG is internalized and retained in the tumor cells.
PURPOSE: To study the feasibility of using 2-deoxy-D-glucose (2-DG)-labeled gold nanoparticle (AuNP-DG) as a computed tomography (CT) contrast agent with tumor targeting capability through in vitro experiments. PROCEDURES: Gold nanoparticles (AuNP) were fabricated and were conjugated with 2-deoxy-D-glucose. The humanalveolar epithelial cancer cell line, A-549, was chosen for the in vitro cellular uptake assay. Two groups of cell samples were incubated with the AuNP-DG and the unlabeled AuNP, respectively. Following the incubation, the cells were washed with sterile PBS to remove the excess gold nanoparticles and spun to cell pellets using a centrifuge. The cell pellets were imaged using a microCT scanner immediately after the centrifugation. The reconstructed CT images were analyzed using a commercial software package. RESULTS: Significant contrast enhancement in the cell samples incubated with the AuNP-DG with respect to the cell samples incubated with the unlabeled AuNP was observed in multiple CT slices. CONCLUSIONS: Results from this study demonstrate enhanced uptake of 2-DG-labeled gold nanoparticle by cancer cells in vitro and warrant further experiments to study the exact molecular mechanism by which the AuNP-DG is internalized and retained in the tumor cells.
Authors: Bernard R Landau; Chandra L Spring-Robinson; Raymond F Muzic; Nadia Rachdaoui; Darrell Rubin; Marc S Berridge; William C Schumann; Visvanathan Chandramouli; Timothy S Kern; Faramarz Ismail-Beigi Journal: Am J Physiol Endocrinol Metab Date: 2007-04-03 Impact factor: 4.310
Authors: Michael J Bonvento; William H Moore; Terry M Button; Hanns-Joachim Weinmann; Renat Yakupov; F Avraham Dilmanian Journal: Acad Radiol Date: 2006-08 Impact factor: 3.173
Authors: Ximei Qian; Xiang-Hong Peng; Dominic O Ansari; Qiqin Yin-Goen; Georgia Z Chen; Dong M Shin; Lily Yang; Andrew N Young; May D Wang; Shuming Nie Journal: Nat Biotechnol Date: 2007-12-23 Impact factor: 54.908
Authors: Ross I Berbeco; Houari Korideck; Wilfred Ngwa; Rajiv Kumar; Janki Patel; Srinivas Sridhar; Sarah Johnson; Brendan D Price; Alec Kimmelman; G Mike Makrigiorgos Journal: Radiat Res Date: 2012-11-13 Impact factor: 2.841
Authors: Jay F Dorsey; Lova Sun; Daniel Y Joh; Alon Witztum; Gary D Kao; Michelle Alonso-Basanta; Stephen Avery; Stephen M Hahn; Ajlan Al Zaki; Andrew Tsourkas Journal: Transl Cancer Res Date: 2013-08-01 Impact factor: 1.241